clinmedaffairs.com

ClinMed Affairs

Paving healthcare opportunities

About

ClinMed leverages decades of experience in global medical research, patient-focused drug development, digital health, and consortia-driven approaches.
By combining scientific rigor and market creativity, we help organizations from the biotechnology, pharmaceutical, health technology, and medical cannabis industries with a broad range of services:
  • Clinical & Medical Affairs
  • Communications
  • Business Development & Commercial Assessment

Why Us?

At ClinMed, we understand that the pace and the face of business has changed with Covid-19.  
For support, we can quickly integrate into your in-house teams, work with your stakeholders, provide independent deliverables, or any combination thereof.
With a broad knowledge base and innovative approach, we’ll help you identify, prioritize, and execute on what matters most to you and your for-profit or nonprofit organization.
Most importantly, along with you, we pave opportunities to improve patients’ lives.

Services

Clinical & Medical Affairs

  • clinical research strategies & study designs (registrational, post-marketing,
    observational, registry); medical operating plans; clinical operations; regulatory strategies
  • Scale development – CoA Clinical Outcome Assessments, PROs Patient Reported Outcomes, electronic scale adaptation
  • digital health applications – objectives, choice of technology, study design
  • medical affairs strategic roadmap; training of MSL teams
  • KOL identification, profiling and relationship building
  • Advisory Boards, Steering Committees – charter, preparation, and moderation
  • professional societies; patient advocacy; pre-competitive consortia – mapping, support & relationship building;
  • HEOR/market access/pricing & reimbursement – strategies and readiness
  • non-dilutive funding strategies; grant development
  • AI in healthcare – applying a suitability framework
business

Communications

  • publication planning: gap analysis, scientific platform, scientific positioning & lexicon
  • medical writing/editing: conference abstracts/posters, primary and secondary manuscripts
  • websites, educational materials, FAQs, objection handlers
  • promotional material; investor material; slide content development
 

Business Development & Commercial Assessment

  • intellectual property portfolio: strategy, prosecution
  • upstream marketing: medical needs, competitive intelligence, segmentation
    & differentiation
  • market & marketing research
  • business models, business plans, company presentations
  • technology evaluation
  • due-diligence readiness: ensuring quality, organization, and maximal value

Therapeutic Areas

  • Neurology & Psychiatry: Parkinson’s, Huntington’s, Alzheimer’s diseases; ALS; multiple sclerosis; multiple system atrophy, progressive supranuclear palsy, stroke recovery, bipolar disorder, depression pain
  • Rare genetic diseases: neurological, dermatological, glycogen & lysosomal storage diseases
  • Oncology: breast, bladder, prostate, colon cancers; melanoma, leukemia, lymphoma

Therapeutic Approaches  

  • small molecules
  • antibodies
  • peptides
  • gene therapies
  • cell therapies (CAR-T; stem cell)
  • plant-based medicines

Cheryl Fitzer-Attas, PhD MBA

Cheryl Fitzer-Attas is a PhD/MBA executive with over 20 years of experience in the life sciences industry, including successful positions in start-up, medium sized-biotech, large pharma, and not-for-profit organizations. She is a versatile leader, whose experience extends across varied domains including medical affairs, clinical R&D, regulatory, commercial, and business development.
In recent years, Cheryl has expanded her focus to digital health programs such as the use of wearables in clinical research and the deployment of artificial intelligence in healthcare.


Cheryl is the founder of Platient Research Technologies, a company developing an on-demand digital platform for clinical research in medical cannabis.

Clients